The Original Interleukin Hypothesis concerning Infl ammation as a Complication of ESRD Therapy
Stanley Shaldon, Monte Carlo , Monaco any that led to the formulation of the hypothesis had to be linked to the editorial title, hence the failure of subsequent claims to priority to realise that the original hypothesis specifi cally discussed the infl ammatory basis of many of the complications seen in ESRD patients on dialysis. A more emphatic emphasis was published in 1985 [3] , but again lies buried in the treasure trove of the Proceedings of EDTA. The fi rst volumes (1964) (1965) (1966) (1967) (1968) (1969) can now be seen at the ERA-EDTA website [4] . In addition, numerous publications between 1985 and 1990 clearly referred to these papers and it is to be hoped that their claim to precedence will be re-established.
Sir,
It is a sad day when the original hypothesis relating many of the infl ammatory complications seen in ESRD therapy to interleukin-1 (IL-1), which was published in the original issue of Blood Purifi cation in 1983 under the title 'Haemodialysis Hypotension: The Interleukin Hypothesis', by Lee Henderson, Karl Koch, Charles Dinarello and Stanley Shaldon, is not quoted in the otherwise complete review of the subject recently published in Blood Purifi cation [1] . This hypothesis antedated the cloning of IL-1. The explanation may lie with the title of the original communication [2] . The editorial title concerning haemodialysis hypotension had already been agreed on with the then-editor, Klaus Schaefer. The epiph-Sir, It was, indeed, a happy day when our review [1] related to the role of infl ammation in ESRD caught the attention of yourself, a pioneer in the fi eld of hemodialysis (HD), who had already in 1983 hypothesized that infl ammation was an important contributor to complications of HD. The paper 'Haemodialysis Hypotension: The Interleukin-1 Hypothesis' [2] proposed a 'unifying hypothesis that monocyte release of interleukin-1 is the underlying event'
Reply
Bengt Lindholm, Peter Stenvinkel Karolinska Institutet, Stockholm, Sweden which, in various ways, could contribute to hypotension in HD patients. Although this paper does not discuss the infl ammatory basis of many of the complications seen in dialysis patients, your later publication [3] briefl y discussed the putative links between IL-1 and metabolic, immunological and infl ammatory changes contributing to uremic symptomatology, again in the context of the HD procedure conducted with complement activating membranes. We are sorry that this original contribution was not cited in our review or in other recent reviews -the fact that your paper is not easily found in PubMed might perhaps have contributed to this oversight.
Although the association between infl ammation, as refl ected by elevated C-reactive protein (CRP) levels, and cardiovascular disease has a long history [4] , the 'IL-1 hypothesis' inspired many studies and was for many years cited in articles on Letter to the Editor Blood Purif 2006;24:232-233 233 biocompatibility of HD. This hypothesis stimulated Jonas Bergström to study the effects of HD on protein catabolism [5] . Based on the results of this study and the literature in non-renal patients describing links between cardiovascular disease and CRP [4] , as well as studies showing associations between low S-albumin levels and outcome [6] , Jonas Bergström initiated analyses of CRP in HD patients in the early 1990s.
At ASN 1995, Jonas Bergström [7] reported that CRP predicted survival in HD patients, later published [8] , and proposed links between infl ammation, cardiovascular disease and malnutrition [9] . The original observation in 1995 that CRP predicted survival in ESRD patients stimulated many other investigators, and we subsequently confi rmed that these associations were present in ESRD even before the start of dialysis treatment [10] . Thus, although there are signifi cant infl ammatory signals associated with the HD procedure [11] , the infl ammatory process of chronic kidney disease starts well before the need for HD [12] . Our description above is, of course, not at all complete and many others [e.g. [13] [14] [15] have contributed to the extensive interest we now see in infl ammation in ESRD patients.
Taken together, although the hypothesis proposed by Henderson et al. [2] was confi ned to the problem of dialysis hypotension in the context of complement activating membranes, we recognize your contribution as important for the increasing interest in infl ammation in ESRD patients during the last 10 years.
